Shanghai Haohai Biological Technology Co (SHSE:688366) Dividend Payout Ratio: 0.00 (As of Mar. 2026)


SHSE:688366 Shanghai Haohai Biological Technology Co Ltd SHSE:688366
69 GF Score
Price ¥31.04
GF Value ¥46.11
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Shanghai Haohai Biological Technology Co Dividend Payout Ratio?

Shanghai Haohai Biological Technology Co SHSE:688366 +1.27% 69 Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus rates SHSE:688366 with a GF Score™ of 69/100 and a GF Value™ of ¥46.11 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 134 Biotechnology companies, Shanghai Haohai Biological Technology Co ranks worse than 80.6% on this metric.

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Shanghai Haohai Biological Technology Co's Dividend Payout Ratio for the months ended in Mar. 2026 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shanghai Haohai Biological Technology Co Ltd is 1.03, which seems too high.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's Dividend Payout Ratio or its related term are showing as below:

SHSE:688366' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.24   Max: 1.06
Current: 1.06


During the past 12 years, the highest Dividend Payout Ratio of Shanghai Haohai Biological Technology Co was 1.06. The lowest was 0.17. And the median was 0.24.

SHSE:688366's Dividend Payout Ratio is ranked worse than
80.6% of 134 companies
in the Biotechnology industry
Industry Median: 0.445 vs SHSE:688366: 1.06

As of today (2026-07-04), the Dividend Yield % of Shanghai Haohai Biological Technology Co is 3.22%.

During the past 12 years, the highest Trailing Annual Dividend Yield of Shanghai Haohai Biological Technology Co was 6.48%. The lowest was 1.00%. And the median was 1.98%.

Shanghai Haohai Biological Technology Co's Dividends per Share for the months ended in Mar. 2026 was ¥0.00.

During the past 12 months, Shanghai Haohai Biological Technology Co's average Dividends Per Share Growth Rate was -71.10% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 25.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 19.30% per year.

During the past 12 years, the highest 3-Year average Dividends Per Share Growth Rate of Shanghai Haohai Biological Technology Co was 50.00% per year. The lowest was -18.70% per year. And the median was 12.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Shanghai Haohai Biological Technology Co (SHSE:688366) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Shanghai Haohai Biological Technology Co Dividend Payout Ratio Related Terms


Shanghai Haohai Biological Technology Co Dividend Payout Ratio Historical Data

* Premium members only.

The historical data trend for Shanghai Haohai Biological Technology Co's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co Dividend Payout Ratio Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.25 0.63 0.17 0.66 1.04

Shanghai Haohai Biological Technology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25 Mar26
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.04 0.00 0.00 0.00 0.00

SHSE:688366 vs VRTX, REGN, ALNY: Dividend Payout Ratio Comparison

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co Dividend Payout Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Dividend Payout Ratio falls into.


SHSE:688366
69GF Score
Shanghai Haohai Biological Technology Co Ltd SHSE:688366
Dividend Payout Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Haohai Biological Technology Co Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Shanghai Haohai Biological Technology Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2025 )/ EPS without NRI (A: Dec. 2025 )
=1/ 0.964
=1.04

Shanghai Haohai Biological Technology Co's Dividend Payout Ratio for the quarter that ended in Mar. 2026 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2026 )/ EPS without NRI (Q: Mar. 2026 )
=0/ 0.329
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Dividend Payout Ratio →
What does a Dividend Payout Ratio of 0.00 mean?
Shanghai Haohai Biological Technology Co (SHSE:688366) has a Dividend Payout Ratio of 0.00 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Shanghai Haohai Biological Technology Co and its competitors. Over the past decade, Shanghai Haohai Biological Technology Co's Dividend Payout Ratio has ranged from 0.17 to 1.06. According to the industry distribution chart, Shanghai Haohai Biological Technology Co ranks #108 out of 134 companies in the Biotechnology industry, placing it in the top 80.6%.
Is Shanghai Haohai Biological Technology Co's Dividend Payout Ratio too high?
Shanghai Haohai Biological Technology Co's current Dividend Payout Ratio is 0.00. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 1.06. Based on the distribution chart, Shanghai Haohai Biological Technology Co ranks #108 out of 134 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Shanghai Haohai Biological Technology Co has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Haohai Biological Technology Co's Dividend Payout Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Haohai Biological Technology Co ranks #108 out of 134 companies for Dividend Payout Ratio. This places Shanghai Haohai Biological Technology Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.45. Historically, Shanghai Haohai Biological Technology Co's own Dividend Payout Ratio has ranged from 0.17 to 1.06 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Biotechnology company?
The median Dividend Payout Ratio among Biotechnology companies is 0.45, based on 134 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Shanghai Haohai Biological Technology Co and its competitors. For the Biotechnology industry, the median Dividend Payout Ratio is 0.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Haohai Biological Technology Co's current Dividend Payout Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Haohai Biological Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co (SHSE:688366) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥46.11, compared to a current price of ¥31.04 — trading 32.7% below its estimated fair value. The current Dividend Payout Ratio is 0.00. Shanghai Haohai Biological Technology Co's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Shanghai Haohai Biological Technology Co (SHSE:688366), the current Dividend Payout Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Haohai Biological Technology Co (SHSE:688366) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Haohai Biological Technology Co stock appears to be undervalued. The current stock price of ¥31.04 is trading 32.7% below its estimated GF Value™ of ¥46.11. GuruFocus considers Shanghai Haohai Biological Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:688366:

  • Dividend Payout Ratio: 0.00
  • GF Value™: ¥46.11 vs. price of ¥31.04 (32.7% below fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688366 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Haohai Biological Technology Co Business Description

Other Exchanges 06826:Hong Kong5HB:Germany
Address No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
69GF Score

Get the complete analysis for SHSE:688366

Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥31.04
Price
¥46.11
GF Value